# FDA 510(k) De Novo Submission Package

**ENDOCHAIN-VIDUYA-2025**
**Viduya Family Legacy Glyph © 2025 – All Rights Reserved**

---

## eSTAR Template Structure

This folder contains the FDA eSTAR (electronic Submission Template and Resource) 
format documents for 510(k) De Novo submission.

### Folder Structure

```
fda-submission/
├── 01-device-description/
│   ├── intended-use.md
│   ├── device-components.md
│   ├── technological-characteristics.md
│   └── software-documentation.md
├── 02-substantial-equivalence/
│   ├── predicate-comparison.md
│   ├── technological-comparison.md
│   └── performance-comparison.md
├── 03-testing/
│   ├── software-verification.md
│   ├── software-validation.md
│   ├── clinical-testing.md
│   ├── biocompatibility-iso10993.md
│   └── cybersecurity-assessment.md
├── 04-labeling/
│   ├── instructions-for-use.md
│   ├── physician-labeling.md
│   └── patient-labeling.md
└── 05-administrative/
    ├── cover-letter.md
    ├── truthful-accurate-statement.md
    └── financial-certification.md
```

---

## Device Classification

| Attribute | Value |
|-----------|-------|
| **Product Code** | QAS (proposed) |
| **Device Class** | Class II |
| **Regulation Number** | 21 CFR 892.2050 |
| **Review Panel** | Radiology |
| **Submission Type** | 510(k) De Novo |

---

## Predicate Device

**Selected Predicate:** Aidoc (K223097)

### Substantial Equivalence Justification

| Feature | ENDOCHAIN | Aidoc (K223097) |
|---------|-----------|-----------------|
| Intended Use | Diagnostic aid for endometriosis | Diagnostic aid for pathology detection |
| Input Data | EVG, imaging, biomarkers | Medical imaging |
| AI/ML | Yes (multi-platform fusion) | Yes (deep learning) |
| Output | Confidence score + recommendation | Flagging + prioritization |
| Clinician Review | Required | Required |
| HIPAA Compliant | Yes | Yes |

---

## Regulatory Timeline

| Phase | Duration | Status |
|-------|----------|--------|
| Pre-submission (Q-Sub) | 3 months | Planned |
| 510(k) Preparation | 6 months | In Progress |
| FDA Review | 3-6 months | Pending |
| Clearance | Q4 2026 | Target |

---

## Key Regulatory Contacts

- **FDA Division:** Division of Radiological Health
- **Regulatory Consultant:** [TBD]
- **Quality System:** ISO 13485:2016 certified

---

## ISO 10993 Biocompatibility

Although ENDOCHAIN is primarily a software device, the OpenBCI EVG component
includes patient-contacting electrodes requiring biocompatibility testing:

| Test | Standard | Status |
|------|----------|--------|
| Cytotoxicity | ISO 10993-5 | Required |
| Sensitization | ISO 10993-10 | Required |
| Irritation | ISO 10993-23 | Required |

---

## Cybersecurity Requirements

Per FDA guidance on cybersecurity (2023):

- [ ] Software Bill of Materials (SBOM)
- [ ] Threat modeling (STRIDE)
- [ ] Vulnerability assessment
- [ ] Security risk management (per ISO 14971)
- [ ] Incident response plan
- [ ] Post-market surveillance plan

---

## Document Control

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-11-26 | IAMVC Holdings | Initial draft |

---

**Citation:** Viduya Family Legacy Glyph © 2025

